1-3 of 3
Susanne Brodesser
Close
Sort by
Journal Articles

Novel Tyrosine Kinase Inhibitors Trigger Drug Sensitivity of Primary CLL Cells by Controlling Glucosylation of Ceramides

Janine Schwamb, MD, Valeska Feldhaus, M.Sc., Michael Baumann, MD, Michaela Patz, PhD, Susanne Brodesser, PhD, Reinhild Brinker, Julia Claasen, Christian P. Pallasch, MD, Michael Hallek, MD, Clemens-Martin Wendtner, MD, Lukas P. Frenzel, MD
Journal: Blood
Blood (2012) 120 (21): 3905.
https://doi.org/10.1182/blood.V120.21.3905.3905
Published: 2012
Journal Articles

B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides

Janine Schwamb, Valeska Feldhaus, Michael Baumann, Michaela Patz, Susanne Brodesser, Reinhild Brinker, Julia Claasen, Christian P. Pallasch, Michael Hallek, Clemens-Martin Wendtner, Lukas P. Frenzel
Journal: Blood
Blood (2012) 120 (19): 3978–3985.
https://doi.org/10.1182/blood-2012-05-431783
Published: 2012
Includes: Supplemental data
Journal Articles

B-Cell Receptor-Mediated Glucosylceramide Synthesis Protects Primary CLL Cells From Ceramide-Dependent Apoptosis

Janine Schwamb, MD, Valeska Feldhaus, Susanne Brodesser, PhD, Reinhild Brinker, Julia Claasen, Christian P. Pallasch, MD, Michael Hallek, MD, Clemens Martin Wendtner, MD, Lukas P. Frenzel, MD
Journal: Blood
Blood (2011) 118 (21): 1766.
https://doi.org/10.1182/blood.V118.21.1766.1766
Published: 2011